(firstQuint)Case-control Pilot Study of the Immune Modulating Effect of FEIBA on Patients With Haemophilia A and Inhibitors.

 This is an observational, multicentric, case-control and one-single-visit study of patients with severe haemophilia A and inhibitors against FVIII in therapy with FEIBA(R).

 Two subject groups will be included: Group 1 (cases) will be composed of patients with severe haemophilia A and inhibitors in prophylaxis with FEIBA(R); Group 2 (controls) will be composed of patients with severe haemophilia A and inhibitors on-demand treatment with FEIBA(R).

.

 Case-control Pilot Study of the Immune Modulating Effect of FEIBA on Patients With Haemophilia A and Inhibitors@highlight

This study aims to evaluate the immunomodulatory effect of FEIBA(R) in patients with severe haemophilia A and inhibitors.

